体外受精治疗成本效益分析数据集

数据集获取（Figshare）

• 源站标题：Datasheet1_Does in vitro fertilization (IVF) treatment provide good value for money? A cost-benefit analysis.pdf
• DOI：10.3389/fgwh.2023.971553.s001
• 发布日期：2023-03-01
• 文件数：1 个
• 文件总体积：1.13 MB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Datasheet1_Does_in_vitro_fertilization_IVF_treatment_provide_good_value_for_money_A_cost-benefit_analysis_pdf/22192204

命令行下载

curl -L -o "Datasheet1_Does in vitro fertilization (IVF) treatment provide good value for money? A cost-benefit analysis.pdf" "https://ndownloader.figshare.com/files/39440137"

文件清单

• Datasheet1_Does in vitro fertilization (IVF) treatment provide good value for money? A cost-benefit analysis.pdf（1.13 MB）

文件总体积 1.13 MB（源站 API 实测）。

数据说明

BackgroundUsing traditional health technology assessment (HTA) outcome metrics, such as quality-adjusted life-years, to assess fertility treatments raises considerable methodological challenges because the objective of fertility treatments is to create new life rather than extend, save, or improve health-related quality of life.
ObjectiveThe aim of this study was to develop a novel cost-benefit framework to assess value for money of publicly funded IVF treatment; to determine the number of cost-beneficial treatment cycles for women of different ages; and to perform an incremental cost-benefit analysis from a taxpayer perspective.
MethodsWe developed a Markov model to determine the net monetary benefit (NMB) of IVF treatment by female age and number of cycles performed. IVF treatment outcomes were monetized using taxpayers’’ willingness-to-pay values derived from a discrete choice experiment (DCE). Using the current funding environment as the comparator, we performed an incremental analysis of only funding cost-beneficial cycles. Similar outputs to cost-effectiveness analyses were generated, including net-benefit acceptability curves and cost-benefit planes. We created an interactive online app to provide a detailed and transparent presentation of the results.
ResultsThe results suggest that at least five publicly funded IVF cycles are cost-beneficial in women aged The provision of fertility treatment is valued highly by taxpayers. This novel cost-benefit method overcomes several challenges of conventional cost-effectiveness methods and provides an exemplar for incorporating DCE results into HTA. The results offer new evidence to inform discussions about treatment funding arrangements.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fgwh.2023.971553.s001（source: https://frontiersin.figshare.com/articles/dataset/Datasheet1_Does_in_vitro_fertilization_IVF_treatment_provide_good_value_for_money_A_cost-benefit_analysis_pdf/22192204）。